Latest California Healthline Stories
New Alzheimer’s Drug Raises Hopes — Along With Questions
Clinics serving Alzheimer’s patients are working out the details of who will get treated with the new drug Leqembi. It won’t be for everyone with memory-loss symptoms.
KFF Health News' 'What the Health?': On Abortion Rights, Ohio Is the New Kansas
Nearly a year to the day after Kansas voters surprised the nation by defeating an anti-abortion ballot question, Ohio voters defeated a similar, if cagier, effort to limit access in that state. This week, they rejected an effort to raise the threshold for approval of future ballot measures from a simple majority, which would have made it harder to protect abortion access with yet another ballot question come November. Meanwhile, the number of Americans without health insurance has dropped to an all-time low, though few noticed. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Roubein of The Washington Post, and Emmarie Huetteman of KFF Health News join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews Kate McEvoy, executive director of the National Association of Medicaid Directors, about how the “Medicaid unwinding” is going, as millions have their eligibility for coverage rechecked.
Promising Better, Cheaper Care, Kaiser Permanente’s National Expansion Faces Wide Skepticism
Kaiser Permanente, the California-based health care giant, is looking to dramatically expand its national presence. It’s committed $5 billion to a new unit called Risant Health and has agreed to acquire Pennsylvania-based Geisinger, but skeptics wonder how it will export its unique model to other states.
Lost Medicaid Health Coverage? Here’s What You Need to Know
Patient advocates are tackling the “overwhelming task” of connecting people with health insurance as millions lose coverage due to the end of pandemic protections on Medicaid eligibility.
Pioneering Study Links Testicular Cancer Among Military Personnel to ‘Forever Chemicals’
The military first documented health concerns surrounding chemicals known as PFAS decades ago yet has continued to use firefighting foam made with them. Despite scores of lawsuits by its personnel and high rates of testicular cancer among troops, it has been slow to investigate a connection.
Seeking Medicare Coverage for Weight Loss Drugs, Pharma Giant Courts Black Influencers
Novo Nordisk, the dominant company in the multibillion-dollar market for weight loss drugs, focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease that needs treatment.
What One Lending Company’s Hospital Contracts Reveal About Financing Patient Debt
Within two years of North Carolina’s public university system going into business with AccessOne to finance patients’ payment plans, nearly half of its patients were in loans that charged interest. As federal scrutiny increases on lenders, California Healthline is sharing that contract and others obtained through public records requests.
Amid Lack of Accountability for Bias in Maternity Care, a California Family Seeks Justice
April Valentine’s family wants to know whether racism could have played a role in her death. A California Healthline analysis shows state regulators are ill-equipped to find discrimination in its many forms.
How the Texas Trial Changed the Story of Abortion Rights in America
Stark, plaintive testimony from women denied abortion care represents the start of “the 50-year fight to get rid of Dobbs,” one historian says.
As a Union Pushes to Cap Hospital CEO Pay, It’s Accused of Playing Politics
A union is asking Los Angeles city voters to cap hospital executive pay at the U.S. president’s salary. However, hospitals accuse the union of using the proposal as political leverage, and policy experts question whether the policy, if enacted, would be workable.